by Vincent Anayochukwu Ani

Received: 06 August 2023;  Published: 24 January 2024;  doi: 10.21926/jept.2401002

Energy is a prerequisite to running health facilities and is, therefore, key to the success of the service. Karshi primary healthcare centre (PHC) facility is confronted with an unreliable power supply that leads to a high cost of generating power from diesel to operate its equipment. This facility needs a sustainable and reliable electricity supply and therefore a change in their energy system to enable it improve its quality of healthcare delivery services. A solar energy-based electricity generation system that [...]

by Keith A. Wollen  and John W. Hoyt

Received: 15 February 2019;  Published: 18 April 2019;  doi: 10.21926/obm.geriatr.1902048

Background: Cognitive abilities in Alzheimer’s Disease are usually examined by formal tests conducted in a laboratory or facility. Such tests are useful for determining the severity of the disease but do not indicate the types of cognition exhibited in the daily lives of patients. This study shows significant preservation of cognition and quality of life in the daily routine of a woman with severe Alzheimer’s who was given multiple therapeutic interventions. Alzheimer’s disease involves multiple d [...]

by Chloe Moran  , Hannah Shaw  , Sue Black  and Kay Brewster

Received: 29 July 2022;  Published: 16 January 2023;  doi: 10.21926/obm.icm.2301006

There is increasing evidence for the effectiveness of brief, group-based compassionate mind training (CMT) in reducing shame and self-criticism, and increasing self-compassion. The current evaluation of an 8-week CMT group programme in an NHS Physical Health Psychology Service supports these findings. Based on a cross-diagnostic sample of 25-39 participants with physical health difficulties, results demonstrate significant reduction in depression and anxiety, significant increase in perceived wellbeing and acceptan [...]

by Shalika B. Katugaha  , Oksana Shlobin  , Chris King  , Steve Nathan  , Shambu Aryal  , Kareem Ahmad  and Whitney Brown

Received: 04 September 2020;  Published: 13 October 2020;  doi: 10.21926/obm.transplant.2004120

Strongyloides stercoralis infection derived from the donor in solid organ transplant (SOT) places recipients at risk for hyperinfection syndrome and death. We describe the case of a lung transplant recipient who developed strongyloidiasis presenting with GI symptoms and progressing to diffuse alveolar hemorrhage, bacteremia and multi-organ failure. The patient's clinical course illustrates the life cycle of Strongyloides. For treatment, the patient received ivermectin and albendazole. We advocate that early diagnos [...]

by Peter Newman  and Marie Verschuer

Received: 27 February 2023;  Published: 17 November 2023;  doi: 10.21926/jept.2304036

The transition to net zero cities is a pivotal challenge in the face of climate change. This research introduces a novel methodology termed "Net Zero Corridors," which emphasizes a bottom-up approach to decarbonize urban power and transport systems. By focusing on urban corridors, this method integrates distributed power systems with urban transport, offering a localized solution to the broader challenge of urban decarbonization. Drawing from urban fabric theory and urban metabolism data, the study provides insight [...]

by Qiqi Yu  , Kran Suknuntha  , Weixiong Zhong  , Daniel R. Matson  , Aaron S. Hess  and William N. Rose

Received: 13 February 2022;  Published: 02 June 2022;  doi: 10.21926/obm.transplant.2202160

We report a case of thrombotic microangiopathy (TMA) diagnosed in the kidney allograft of a 59-year-old woman who had developed plasmacytoma type monomorphic posttransplant lymphoproliferative disorder (PTLD) 30 years after a simultaneous pancreas and kidney transplant. This report demonstrates a rare etiology of TMA in a kidney allograft occurring in association with PTLD-associated monoclonal gammopathy. The main teaching points are: 1) PTLD may be considered in the work-up of a new TMA in the immunosuppressed po [...]

by Jessica Turnbull  , Sally Hobson  , Jenna Vyas-Lee  and Bidisha Lahoti

Received: 31 January 2021;  Published: 15 June 2021;  doi: 10.21926/obm.neurobiol.2102101

We describe our experience of setting up and evaluating a community-based multi-disciplinary sleep service for children with neurodevelopmental disorders and psychosocial vulnerabilities.Referrals are accepted for children (1-18 years of age) with persistent sleep problems, and neurodevelopmental difficulties or significant psychosocial adversity, living in two inner-city boroughs.Holistic sleep assessment involves 1-hour Paediatrician-led consultation, often followed by Psychologist-led parent workshop, with follo [...]

by Robert F. Miller  , Laurence Huang  and Peter D. Walzer

Received: 14 September 2018;  Published: 25 October 2018;  doi: 10.21926/obm.genet.1804045

Background: Over the past decade, there has been rising interest in the interaction of Pneumocystis with the environment. This interest has arisen in part from the demonstration that environmental factors have important effects on the viability and transmission of microbes, including Pneumocystis. Environmental factors include climatological factors such as temperature, humidity, and precipitation, and air pollution factors including carbon monoxide, nitrogen dioxide, sulfur dioxide, and particulate matter. Methods [...]

by Grace Douglas  , Andrew S Day  and Stephanie C Brown

Received: 23 August 2024;  Published: 13 December 2024;  doi: 10.21926/rpn.2404020

Dietary and nutritional interventions have been shown to have roles in managing active Crohn disease (CD), with exclusive enteral nutrition (EEN) being recommended as the preferred initial treatment in children following diagnosis. In recent years, other nutritional interventions such as the Crohn's disease exclusion diet (CDED) have been considered and evaluated for induction therapy. To date, the long-term benefits of CDED have not been established. This report highlights the outcomes of the prolonged use of CDED [...]

by Katerina G. Oikonomou  and Sarah Taimur

Received: 14 February 2019;  Published: 17 June 2019;  doi: 10.21926/obm.transplant.1902066

In non-endemic regions of the world, human T-cell lymphotropic virus type-1 (HTLV-1) is an uncommon pathogen in the transplant host, but can be associated with significant morbidity and mortality. Careful assessment for risk factors, targeted screening and heightened awareness of the clinical presentation of HTLV-1 associated disease is necessary for timely recognition and management in the transplant host. The use of antiretroviral agents in the management of symptomatic disease due to HTLV-1 remains controversial [...]